Primary bone cancers include osteosarcoma, Ewing sarcoma, and chondrosarcoma. They
account for less than 1% of diagnosed cancers each year and are associated with significant …

Clinical outcomes and treatment modalities for osteosarcoma, the most common primary
cancer of bone, have changed very little over the past 30 years. The peak incidence of …

Background Osteosarcoma is the most common primary bone malignancy. As a rare cancer,
population‐based studies remain small with limited information on finer demographic …

Survival in osteosarcoma is a story of success on many fronts. What was once a disease that
was rarely curable even with ablative surgery now has a 5-year overall survival approaching …

Abstract lncRNAs regulate the initiation and progression of osteosarcoma, although the
mechanism by which this occurs remains unknown. The present study shows that over …

Introduction: In the early seventies chemotherapy significantly improved survival in
osteosarcoma. Since then minor innovations have occurred although recent years have …

Prostate cancer (PCa) is the leading cause of cancer-related death among men worldwide.
Knowledge of the prognostic factors of PCa and the bone metastasis pattern of patients …

Background A consensus has not yet been reached regarding the abilities of gender, age,
tumor size, tumor location, histologic subtypes, and surgery in the prediction of survival in …

Only few systematic and comprehensive studies have focused on osteosarcoma in children
and adolescents. In the present study, 3,085 patients with osteosarcoma were identified in …

With the development of RNA modification research, the importance of N6-methyladenosine
(m6A) in tumors cannot be ignored. m6A promotes the self-renewal of tumor stem cells and …